Vaccines Are Perfectly Safe, Unless You’re Young and Swedish
A vaccine that’s deemed safe for some people may not be deemed safe for others. Take the Moderna vaccine, which North American governments endorse for those under 30 years of age. If you’re a 29-year-old Swede, your government decided against authorizing its use as of Dec. 1, continuing a pause it began in early October. Finland has a similar prohibition, while Denmark touts the Moderna vaccine for people over, but not under, 18. Iceland discontinued the use of Moderna altogether.
These Scandinavian countries’ authorities fear Moderna causes needless risk of myocarditis in young people, especially in young males and especially after getting the second shot. Their health authorities instead steer people to the low-dose Pfizer vaccine, which provides 30 micrograms of mRNA, the live agent, compared to Moderna’s 100 micrograms.
France’s High Authority for Health not only didn’t recommend Moderna for under 30-year-olds, it also removed its recommendation last month for anyone, of any age, for a Moderna booster, even though it explicitly recommends Moderna over Pfizer for those over 30 for the first two doses. Authorities in the United States and Canada have no such prohibitions, even though for young males Moderna has a myocarditis rate of five times that of the Pfizer.
The Pfizer vaccine has its share of concerns. In November, Taiwan’s Central Epidemic Command Center decided to pause Pfizer’s second shot in 12- to 17-year-olds after 16 Taiwanese teens developed myocarditis. Taiwan will restart jabbing youngsters in mid-December, with the recommendation that the second shot be taken 12 weeks after receiving the first shot, but maybe not if the child has an adverse reaction to the first shot. Taiwan recognizes that the Pfizer vaccine increases the chances of contracting myocarditis, especially in young boys, and requires letters of intent and parental consent before a child can be jabbed.
Other concerns over Pfizer threaten to lead to future restrictions. While Pfizer raises fewer red flags than Moderna over myocarditis, it raises more over breakthrough infections, which hit Pfizer vaccinees 57 percent more often than those vaccinated with Moderna.
Experience the best way to read The Epoch Times online. Try our free app for a limited time.
The mainstream media in Israel, the poster child for mass vaccination using Pfizer, has of late been in open debate about Pfizer’s value, with the medical director of Israel’s leading center for respiratory care stating in early August that Israel’s vaccinated accounted for 85 to 90 percent of COVID hospitalizations at Jerusalem’s Herzog Medical Center.
No comments:
Post a Comment